Systematic Search for Variation in the Human Norepinephrine Transporter Gene: Identification of Five Naturally Occurring Missense Mutations and Study of Association with Major Psychiatric Disorders

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 6, 1996, Pages 523-532

  Stöber, Gerald ^a,b   Nöthen, Markus M ^a   Pörzgen, Peter ^a   Brüss, Michael ^a   Bönisch, Heinz ^a   Knapp, Michael ^a   Beckmann, Helmut ^b   Propping, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bipolar affective disorder; Genetic variant; Imprinting; Mutation analysis; Noradrenaline; Norepinephrine; Schizophrenia; Transporter

Indexed keywords

STAPHYLOCOCCUS PHAGE 187;

COMPLEMENTARY DNA; DNA; NORADRENALIN;

AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA SEQUENCE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MISSENSE MUTATION; MOLECULAR CLONING; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; ALLELES; CARRIER PROTEINS; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; HUMANS; INTRONS; MODELS, MOLECULAR; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RESTRICTION MAPPING; SYMPORTERS;

EID: 0029838815     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19961122)67:6<523::AID-AJMG3>3.0.CO;2-I     Document Type: Article

References (47)

1. Amara SG, Kuhar MJ (1993): Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
2. American Psychiatric Association (1987): "Diagnostic and Statistical Manual of Mental Disorders," 3rd edn. revised. DC: American Psychiatric Press, Washington.
3. Auld VJ, Goldin AL, Krafte DS, Catterall W, Lester HA, Davidson N, Dunn R (1990): A neutral amino acid change in segment IIS4 dramatically alters the gating properties of the voltage-dependent sodium channel. Proc Natl Acad Sci USA 87:323-327.
4. Beckmann H, Goodwin FK (1980): Urinary MHPG in subgroups of depressed patients and normal controls. Neuropsychobiology 6: 91-100.
5. Bönisch H, Brüss M (1994): The noradrenaline transporter of the neuronal plasma membrane. Ann NY Acad Sci 733:193-202.
6. Brüss M, Kunz J, Lingen B, Bönisch H (1993): Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet 91:278-280.
7. Buck KJ, Amara SG (1994): Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588.
8. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991): Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137-144.
9. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. Cichon S, Nöthen MM, Wolf HK, Propping P (1995): Lack of imprinting of the human dopamine D4 receptor (DRD4) gene. Am J Med Genet (Neuropsychiatr Genet) 67:229-231.
11. DeChiara TM, Robertson EJ, Efstratiadis A (1991): Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64: 849-859.
12. DiBella D, Catalano M, Balling U, Smeraldi E, Lesch KP (1995): Systematic screening for mutations in the coding region of the 5 HTT gene using PCR and DGGE. Psychiatric Genet 5 (Suppl. 1):100.
13. Endicott J, Spitzer RL (1978): A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837-844.
14. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM (1993): Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res 602:161-164.
15. Gattaz WF, Waldmeier P, Beckmann H (1982): CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand 66: 350-360.
16. Gelernter J, Kruger S, Pakstis AJ, Pacholczyk T, Sparkes RS, Kidd KK, Amara SG (1993): Assignment of the norepinephrine transporter protein (NET 1) locus to chromosome 16. Genomics 18: 690-692.
17. Giros B, El Mestikawy S, Godinot N, Zheng K, Han H, Yang-Fen T, Caron MG (1992): Cloning, pharmacological characterization and chromosomal assignment of the human dopamine transporter. Mol Pharmacol 42:383-390.
18. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994): Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269:15985-15988.
19. Greenberg DA (1993): Linkage analysis of "necessary" disease loci versus "susceptibility loci." Am J Hum Genet 52:135-143.
20. Hadley D, Hoff M, Holik J, Reimherr F, Wender P, Coon H, Byerley W (1995): Manic-depression and the norepinephrine transporter gene. Hum Hered 45:165-168.
21. Hall JK (1990): Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 106:857-873.
22. Hayashi K, Yandell DW (1993): How sensitive is PCR-SSCP? Hum Mutation 2:338-346.
23. Hoffman BJ (1994): Expression cloning of a serotonin transporter: A new way to study antidepressant drugs. Pharmacopsychiatry 27:16-22.
24. Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE, Niikawa N (1994): Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet 6:305-309.
25. King SC, Tiller AA, Chang AS-S, Lam DM-K (1992): Differential regulation of the imipramine-sensitive serotonin transporter by cAMP in human HJAR choriocarcinoma cells, rat PC 12 pheochromocytoma cells, and C33-14-B1 transgenic mouse fibroblast cells. Biochem Biophys Res Commun 183:487-491.
26. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992): Dopamine transporter site directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785.
27. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P (1993): Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91:67-72.
28. Lingen B, Brüss M, Bönisch H (1994): Cloning and expression of the bovine sodium- and chloride-dependent norardenaline transporter. FEBS Lett 342:235-238.
29. Linnoila M, Ninan PT, Scheinin M, Waters RN, Chang WH, Barko J, van Kammen DP (1983): Reliability of norepinephrine and major monoamine metabolite measurement in CSF of schizophrenic patients. Arch Gen Psychiatry 40:1290-1294.
30. McCormack K, Lin L, Sigworth FJ (1993): Substitution of a hydrophobic residue alters the conformational stability of shaker K+ channels during gating and assembly. Biophys J 65:1740-1748.
31. Miller SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
32. Nelson N, Lill H (1994): Porters and neurotransmitter transporters. J Exp Biol 196:213-228.
33. Nöthen MM, Propping P, Fimmers R (1993): Association versus linkage studies in psychosis genetics. J Med Genet 30:634-637.
34. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 5:874-879.
35. Pacholczyk T, Blakely RD, Amara SG (1991): Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354.
36. Propping P, Nöthen MM (1995): Genetic variation of CNS receptors: A new perspective for pharmacogenetics. Pharmacogenetics 5:318-325.
37. Pörzgen P, Bönisch H, Brüss M (1995): Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 215:1145-1150.
38. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Fen T, Chang AS, Ganapathy V, Blakely RD (1993): Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
39. Roy A, Pickar D, Linnoila M, Potter WZ (1985): Plasma norepinephrine level in affective disorders. Relationship to melancholia. Arch Gen Psychiatry 42:1181-1185.
40. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
41. Shapiro M, Senapathy P (1987): RNA splice junctions of different classes of eukaryontes: Sequence statistics and fundamental implication in gene expression. Nucl Acids Res 15:7155-7174.
42. Szot P, Ashliegh EA, Kohen R, Petrie E, Dorsa DM, Veith R (1993): Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res 618:308-312.
43. Uhl GR, Johnson PS (1994): Neurotransmitter transporter: three important gene families for neuronal function. J Exp Biol 196: 229-236.
44. Vandenbergh DJ, Persico AM, Uhl GR (1992): A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element, and provides racially-dimorphic Taq I RFLPs. Mol Brain Res 15:161-166.
45. van Kammen DP, Agren H, Yao JK, O'Connor DT, Gurklis J, Peters JL (1994): Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. Am J Psychiatry 151:379-384.
46. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER, Pascualy M, Halter JB (1994): Sympathetic nervous system activity in major depression. Arch Gen Psychiatry 51:411-422.
47. Vrana KE, Walker SJ, Rucker P, Liu X (1994): A carboxyl terminal leucine zipper is required for tyrosine hydroxylase tetramer formation. J Neurochem 63:2014-2020.